These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 7966534)
41. Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan. Zijlstra EE; Ali MS; el-Hassan AM; el-Toum IA; Satti M; Ghalib HW; Kager PA Trans R Soc Trop Med Hyg; 1991; 85(4):474-6. PubMed ID: 1755052 [TBL] [Abstract][Full Text] [Related]
43. Immunofluorescence and counter immunoelectrophoresis in the diagnosis of kala-azar. Rezai HR; Behforouz N; Amirhakimi GH; Kohanteb J Trans R Soc Trop Med Hyg; 1977; 71(2):149-51. PubMed ID: 327629 [TBL] [Abstract][Full Text] [Related]
44. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar. Salotra P; Raina A; Negi NS Br J Biomed Sci; 1999; 56(4):263-7. PubMed ID: 10795370 [TBL] [Abstract][Full Text] [Related]
45. [Visceral leishmaniasis contracted in Europe (kala-azar)]. Reincke M; Allolio B; Hackenberg E; Cohen S; Winkelmann W; Kaufmann W Med Klin (Munich); 1990 Apr; 85(4):220-3. PubMed ID: 2191212 [No Abstract] [Full Text] [Related]
46. Diagnosis of symptomatic kala-azar by polymerase chain reaction using patient's blood. Pal S; Aggarwal G; Haldar A; Majumdar A; Majumdar HK; Duttagupta S Med Sci Monit; 2004 Jan; 10(1):MT1-5. PubMed ID: 14704640 [TBL] [Abstract][Full Text] [Related]
47. Presence of anti-Lepp12 antibody: a marker for diagnostic and prognostic evaluation of visceral leishmaniasis. Kumar D; Srividya G; Verma S; Singh R; Negi NS; Fragaki K; Kubar J; Salotra P Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):167-71. PubMed ID: 18177681 [TBL] [Abstract][Full Text] [Related]
48. Application of electroimmunodiffusion and crossed electroimmunodiffusion tests for the diagnosis of visceral leishmaniasis (kala-azar). Kohanteb J; Rezai HR; Ardehali S J Trop Med Hyg; 1984 Oct; 87(5):201-5. PubMed ID: 6442365 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of enzyme-linked immunosorbent assay in the diagnosis of kala-azar in Malda district (West Bengal). Gupta S; Srivastava JK; Ray S; Chandra R; Srivastava VK; Katiyar JC Indian J Med Res; 1993 Nov; 97():242-6. PubMed ID: 8144206 [TBL] [Abstract][Full Text] [Related]
50. Recent advances in the diagnosis and treatment of kala-azar. Sundar S; Chakravarty J Natl Med J India; 2012; 25(2):85-9. PubMed ID: 22686715 [TBL] [Abstract][Full Text] [Related]
51. [Evaluation of prevalent status of kala-azar in endemic area of Hubei Province]. Gui AF; Zuo SL; Wu JH; Gui XE; Hu LQ; Yang LD; Zhang SQ Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(3):170-2. PubMed ID: 12567700 [TBL] [Abstract][Full Text] [Related]
52. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Singh S; Kumari V; Singh N Clin Diagn Lab Immunol; 2002 May; 9(3):568-72. PubMed ID: 11986261 [TBL] [Abstract][Full Text] [Related]
53. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. Zijlstra EE; Nur Y; Desjeux P; Khalil EA; El-Hassan AM; Groen J Trop Med Int Health; 2001 Feb; 6(2):108-13. PubMed ID: 11251906 [TBL] [Abstract][Full Text] [Related]
54. Field evaluation of a fast anti-Leishmania antibody detection assay in Ethiopia. Hailu A; Schoone GJ; Diro E; Tesfaye A; Techane Y; Tefera T; Assefa Y; Genetu A; Kebede Y; Kebede T; Schallig HD Trans R Soc Trop Med Hyg; 2006 Jan; 100(1):48-52. PubMed ID: 16203020 [TBL] [Abstract][Full Text] [Related]
55. [Visceral leishmaniasis in Cameroon. Seroepidemiologic survey in the Kousseri region, north Cameroon]. Dondji B; Dereure J; Poste B; Same-Ekobo A; Dedet JP Bull Soc Pathol Exot; 2001 Dec; 94(5):418-20. PubMed ID: 11889946 [TBL] [Abstract][Full Text] [Related]
56. Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients. Anam K; Afrin F; Banerjee D; Pramanik N; Guha SK; Goswami RP; Gupta PN; Saha SK; Ali N Clin Diagn Lab Immunol; 1999 Mar; 6(2):231-5. PubMed ID: 10066659 [TBL] [Abstract][Full Text] [Related]
57. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India. Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384 [TBL] [Abstract][Full Text] [Related]
58. Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India. Ejazi SA; Bhattacharya P; Bakhteyar MA; Mumtaz AA; Pandey K; Das VN; Das P; Rahaman M; Goswami RP; Ali N PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005035. PubMed ID: 27741241 [TBL] [Abstract][Full Text] [Related]
59. Comparison of serological methods (ELISA, DAT and IFA) for diagnosis of visceral leishmaniasis utilizing an endemic strain. Mikaeili F; Fakhar M; Sarkari B; Motazedian MH; Hatam G Iran J Immunol; 2007 Jun; 4(2):116-21. PubMed ID: 17652852 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of enzyme-linked immunosorbent assay for diagnosis of post-kala-azar dermal leishmaniasis with crude or recombinant k39 antigen. Salotra P; Sreenivas G; Nasim AA; Subba Raju BV; Ramesh V Clin Diagn Lab Immunol; 2002 Mar; 9(2):370-3. PubMed ID: 11874880 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]